Teleb Mohamed S, Asif Kaiz, Castonguay Alicia C, Zaidat Osama O
Division of Neurointervention, Department of Neurology, Froedtert Hospital and Medical College of Wisconsin, 9200 West Wisconsin Ave, Milwaukee, WI 53226, USA.
Division of Neurointervention, Department of Neurology, Froedtert Hospital and Medical College of Wisconsin, 9200 West Wisconsin Ave, Milwaukee, WI 53226, USA.
Neurosurg Clin N Am. 2014 Jul;25(3):593-605. doi: 10.1016/j.nec.2014.04.014. Epub 2014 May 28.
Intracranial atherosclerotic disease (ICAD) represents one of the most common causes of ischemic stroke worldwide, yet our understanding remains limited regarding the best treatment options for this complex disease with a high recurrence rate of stroke. Although medical therapy has proved to be effective in lowering the risk of stroke, certain high-risk ICAD patients may derive benefit from endovascular therapy. This review presents the current treatment options for the endovascular management of ICAD and highlights the recent relevant literature.
颅内动脉粥样硬化性疾病(ICAD)是全球缺血性卒中最常见的病因之一,但对于这种具有高卒中复发率的复杂疾病的最佳治疗方案,我们的了解仍然有限。尽管药物治疗已被证明在降低卒中风险方面有效,但某些高危ICAD患者可能从血管内治疗中获益。本文综述了ICAD血管内治疗的当前治疗方案,并重点介绍了近期的相关文献。